Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Lippo Karawaci TbkPTLKF 68 Net Margin % is 6.07% as of Mar. 2026, which is 116% above its 10-year median of 2.81. GuruFocus rates PTLKF with a GF Score™ of 68/100 and a GF Value™ of $0.01. The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, PT Lippo Karawaci Tbk ranks better than 59.49% on this metric.
The historical rank and industry rank for PT Lippo Karawaci Tbk's Net Margin % or its related term are showing as below:
PTLKF'
s Net Margin % Range Over the Past 10 Years
Min: -75.28 Med: 2.81 Max: 165.19
Current: 4.74
PTLKF's Net Margin % is ranked better than 59.49% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs PTLKF: 4.74
PT Lippo Karawaci Tbk (OTCPK:PTLKF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PT Lippo Karawaci Tbk Net Margin % Related Terms
PT Lippo Karawaci Tbk Net Margin % Historical Data
* Premium members only.
The historical data trend for PT Lippo Karawaci Tbk's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Lippo Karawaci Tbk's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Lippo Karawaci Tbk Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Lippo Karawaci Tbk's Net Margin % distribution charts can be found below:
* The bar in red indicates where PT Lippo Karawaci Tbk's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Lippo Karawaci Tbk (PTLKF) has a Net Margin % of 6.07% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on PT Lippo Karawaci Tbk and its competitors. This is 116% above median its historical median of 2.81. According to the industry distribution chart, PT Lippo Karawaci Tbk ranks #269 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 40.5%.
Is PT Lippo Karawaci Tbk's Net Margin % too high?
PT Lippo Karawaci Tbk's current Net Margin % of 6.07% is 116% above median its 10-year median of 2.81. The Healthcare Providers & Services industry median Net Margin % is 2.92. PT Lippo Karawaci Tbk's value of 6.07% is 108.2% above this industry median. Based on the distribution chart, PT Lippo Karawaci Tbk ranks #269 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Lippo Karawaci Tbk has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does PT Lippo Karawaci Tbk's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Lippo Karawaci Tbk ranks #269 out of 664 companies for Net Margin %. This puts PT Lippo Karawaci Tbk in the upper half of its industry. The industry median Net Margin % is 2.92. PT Lippo Karawaci Tbk's value of 6.07% is 108.2% above this benchmark. While the company's 10-year median is 2.81 vs. the industry median of 2.92, PT Lippo Karawaci Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Lippo Karawaci Tbk's current Net Margin % of 6.07% is 108.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on PT Lippo Karawaci Tbk and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Lippo Karawaci Tbk's current Net Margin % is 6.07%, which is 116% above median its own 10-year median of 2.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Lippo Karawaci Tbk stock overvalued right now?
PT Lippo Karawaci Tbk (PTLKF) has a current Net Margin % of 6.07%. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 4% above its estimated fair value. The current Net Margin % is 6.07%, which is 116% above median its 10-year median of 2.81 and 108.2% above the Healthcare Providers & Services industry median of 2.92. PT Lippo Karawaci Tbk's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For PT Lippo Karawaci Tbk (PTLKF), the current Net Margin % is 6.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Lippo Karawaci Tbk (PTLKF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Lippo Karawaci Tbk stock appears to be overvalued.
The current stock price of $0.01 is trading 4% above its estimated GF Value™ of $0.01.
Key valuation signals for PTLKF:
Net Margin %: 6.07% (116% above median its 10-year median of 2.81)
GF Value™: $0.01 vs. price of $0.01 (4% above fair value)
Industry Position: 108.2% above the Healthcare Providers & Services median (#269 of 664)
No single metric tells the full story. See the PTLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Lippo Karawaci Tbk is engaged in property development activities including area development, residential property development and sales, commercial property, light industrial property, and integrated property projects. As part of its large scale integrated development portfolio, the Company develops projects within strategic locations comprising residential, office, mall, hotel, entertainment, education, and healthcare facilities. Its portfolio includes residential and urban development, hospitals, malls, and hotels and leisure assets. The Company has developed and manages urban property areas mainly in Java and Sulawesi, and operates across real estate, lifestyle, and healthcare segments, providing services across Indonesia.
68GF Score
Get the complete analysis for PTLKF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PTLKF has been successfully added to your 
